Equity Capital Markets
Nektar Therapeutics
06/25
|
$100.0 Million
Âé¶¹´«Ã½ served as bookrunner for Nektar Therapeutics on its CMFO
Sub-Type
CMFO
Sector
Sub-Sector
Biopharma